Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.6067
+0.0322 (5.60%)
At close: Mar 31, 2026, 4:00 PM EDT
0.6199
+0.0132 (2.18%)
After-hours: Mar 31, 2026, 7:58 PM EDT

Humacyte Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
135180657294218747
Market Cap Growth
-65.22%-72.61%123.02%35.18%-70.83%1173.56%
Enterprise Value
149.55191.8689.56268.88113.69570.43
Last Close Price
0.610.965.052.842.117.25
PE Ratio
--3.69-4.01-2.65-17.58-10.98
PS Ratio
66.0988.26--139.18591.27
PB Ratio
37.6657.86-12.4721.741.866.11
P/TBV Ratio
30.8548.86-11.3621.681.862.37
P/FCF Ratio
--1.70-6.59-3.90-3.02-9.17
P/OCF Ratio
--1.71-6.69-4.02-3.06-9.20
EV/Sales Ratio
73.3894.11--72.65451.64
EV/EBITDA Ratio
--1.90-6.43-2.91-1.49-7.82
EV/EBIT Ratio
--1.77-6.03-2.69-1.34-7.02
EV/FCF Ratio
--1.81-6.92-3.56-1.58-7.01
Debt / Equity Ratio
20.0820.08-1.484.050.410.40
Debt / EBITDA Ratio
-0.64-0.64-0.75-0.62-0.77-0.70
Debt / FCF Ratio
-0.61-0.61-0.81-0.76-0.81-0.63
Net Debt / Equity Ratio
4.624.62-0.68-1.70-0.80-1.43
Net Debt / EBITDA Ratio
-0.14-0.14-0.330.251.222.39
Net Debt / FCF Ratio
-0.13-0.13-0.360.301.292.14
Asset Turnover
0.020.02000.010.01
Inventory Turnover
1.431.43----
Quick Ratio
2.772.772.254.367.7620.42
Current Ratio
3.693.692.404.527.8820.75
Return on Equity (ROE)
164.78%164.78%760.17%-169.81%-8.70%22.10%
Return on Assets (ROA)
-85.07%-85.07%-85.98%-60.17%-34.46%-41.30%
Return on Invested Capital (ROIC)
-170.37%-170.37%-209.97%-264.45%-176.39%-144.92%
Return on Capital Employed (ROCE)
-100.17%-100.17%-100.48%-67.94%-36.76%-43.79%
Earnings Yield
-30.31%-27.07%-24.95%-37.68%-5.69%-9.10%
FCF Yield
-78.64%-58.89%-15.18%-25.67%-33.14%-10.90%
Buyback Yield / Dilution
-33.49%-33.49%-14.56%-0.36%-157.82%0.00%
Total Shareholder Return
-33.49%-33.49%-14.56%-0.36%-157.82%0.00%
Updated Mar 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q